LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · IEX Real-Time Price · USD
86.20
+0.89 (1.04%)
At close: Jul 19, 2024, 4:00 PM
86.27
+0.07 (0.08%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
LeMaitre Vascular Revenue
LeMaitre Vascular had revenue of $199.89M in the twelve months ending March 31, 2024, with 18.16% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $53.48M with 13.60% year-over-year growth. In the year 2023, LeMaitre Vascular had annual revenue of $193.48M with 19.69% growth.
Revenue (ttm)
$199.89M
Revenue Growth
+18.16%
P/S Ratio
9.68
Revenue / Employee
$317,281
Employees
630
Market Cap
1.93B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 193.48M | 31.83M | 19.69% |
Dec 31, 2022 | 161.65M | 7.23M | 4.68% |
Dec 31, 2021 | 154.42M | 25.06M | 19.37% |
Dec 31, 2020 | 129.37M | 12.13M | 10.35% |
Dec 31, 2019 | 117.23M | 11.66M | 11.05% |
Dec 31, 2018 | 105.57M | 4.70M | 4.66% |
Dec 31, 2017 | 100.87M | 11.72M | 13.14% |
Dec 31, 2016 | 89.15M | 10.80M | 13.78% |
Dec 31, 2015 | 78.35M | 7.26M | 10.20% |
Dec 31, 2014 | 71.10M | 6.55M | 10.14% |
Dec 31, 2013 | 64.55M | 7.81M | 13.77% |
Dec 31, 2012 | 56.74M | -950.00K | -1.65% |
Dec 31, 2011 | 57.69M | 1.63M | 2.90% |
Dec 31, 2010 | 56.06M | 5.15M | 10.12% |
Dec 31, 2009 | 50.91M | 2.19M | 4.49% |
Dec 31, 2008 | 48.72M | 7.27M | 17.55% |
Dec 31, 2007 | 41.45M | 6.82M | 19.69% |
Dec 31, 2006 | 34.63M | 3.90M | 12.70% |
Dec 31, 2005 | 30.73M | 4.54M | 17.35% |
Dec 31, 2004 | 26.18M | 5.52M | 26.71% |
Dec 31, 2003 | 20.66M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Alignment Healthcare | 2.01B |
National HealthCare | 1.17B |
Novavax | 996.61M |
Warby Parker | 697.80M |
Amphastar Pharmaceuticals | 676.21M |
NovoCure | 525.66M |
Mirum Pharmaceuticals | 224.00M |
Arvinas | 71.30M |
LMAT News
- 5 days ago - LeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, 2024 - GlobeNewsWire
- 2 months ago - LeMaitre to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - LeMaitre Q1 2024 Financial Results - GlobeNewsWire
- 3 months ago - LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024 - GlobeNewsWire
- 4 months ago - LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 months ago - LeMaitre to Participate at Upcoming Investor Conferences in March - GlobeNewsWire
- 5 months ago - LeMaitre Q4 2023 Financial Results - GlobeNewsWire
- 5 months ago - LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024 - GlobeNewsWire